Response Biomedical Leases New Long-Term Facility
Duane Morris, Response Biomedical's Chief Operating Officer, added "As we scale up manufacturing to meet the anticipated needs of our current partners, Shionogi and 3M Medical, it is extremely important that we have a long-term facility with the capacity to meet projected demand. Further, we expect to require additional production capacity for our very promising cardiovascular platform, particularly with the US approval and launch of the RAMP NT-proBNP test expected later this year. This facility will be custom designed and we believe will meet our demands for years to come. We are truly fortunate, in this very tight commercial real estate environment, to find such a tremendous fit and to be working with such a stellar company as Alexandria."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.